Press release
Primary Catalyst Driving Superdisintegrants Market Evolution in 2025: Rising Generic Drug Production Fuels The Market Growth Driver
Superdisintegrants
Increasing generic drug production is expected to propel the growth of the superdisintegrants market in the future. A generic drug is a medication that has the same active ingredients, dosage, strength, route of administration, quality, and performance as a brand-name drug but is typically sold at a lower cost. Increasing generic drug production is driven by the rising demand for affordable medications, patent expirations of branded drugs, and government initiatives to reduce healthcare costs. Superdisintegrants in generic drugs enhance tablet disintegration and dissolution, ensuring faster drug release, improved bioavailability, and better patient compliance. For example, in January 2023, according to a report from the Food and Drug Administration (FDA), a U.S.-based government department, it was estimated that 91% of prescriptions in the United States were filled with generic drugs, with over 32,000 generic medications approved by the FDA to date. Therefore, the increasing production of generic drugs is driving the growth of the superdisintegrants market.
Get Your Superdisintegrants Market Report Here:
https://www.thebusinessresearchcompany.com/report/superdisintegrants-global-market-report
How will the growth rate of the superdisintegrants market shape industry trends by 2034?
The superdisintegrants market has expanded significantly, growing from $1.09 billion in 2024 to $1.16 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rising prevalence of chronic and lifestyle-related diseases, an expanding global pharmaceutical industry, increased demand for orally disintegrating tablets (ODTs), a growing geriatric and pediatric population, and an increasing focus on enhancing drug bioavailability.
The superdisintegrants market is poised for strong expansion, reaching $1.48 billion by 2029 at a CAGR of 6.3%. Growth factors include increasing demand for oral solid dosage forms, a growing prevalence of chronic diseases, an expanding pharmaceutical manufacturing sector, and a rising need for effective drug formulations. Key trends during this period include technological advancements in manufacturing, the development of co-processed excipients, a shift toward natural and biodegradable superdisintegrants, the creation of innovative drug-delivery systems, and collaborations between excipient manufacturers and pharmaceutical companies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21292&type=smp
What trends are poised to drive the future success of the superdisintegrants market?
In the superdisintegrants market, companies are focusing on multifunctional disintegrants to enhance drug formulation efficiency, optimize tablet disintegration, and improve patient compliance. A multifunctional disintegrant combines disintegration, binding, and flow-enhancing properties to improve formulation efficiency. For instance, in June 2023, Ashland Inc. launched Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant that enhances tablet disintegration and supports high-speed manufacturing.
Which primary segments of the superdisintegrants market are driving growth and industry transformations?
The superdisintegrants market covered in this report is segmented -
1) By Type: Natural Superdisintegrants, Synthetic Superdisintegrants, Other Superdisintegrants
2) By Formulation: Tablets, Capsules
3) By Therapeutic Area: Gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Hematological Diseases
Subsegments:
1) By Natural Superdisintegrants: Starch, Cellulose, Chitosan, Gums, Other Natural Superdisintegrants
2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone), Sodium Starch Glycolate, Croscarmellose Sodium, Other Synthetic Superdisintegrants
3) By Other Superdisintegrants: Ion Exchange Resins, Surfactant-Based Superdisintegrants, Other Specialized Superdisintegrants
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21292
Which geographical regions are pioneering growth in the superdisintegrants market?
North America was the largest region in the superdisintegrants market in 2024. The regions covered in the superdisintegrants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the superdisintegrants market landscape?
Major companies operating in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., JH Nanhang Life Sciences Co. Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21292&type=smp
What Is Covered In The Superdisintegrants Global Market Report?
•Market Size Forecast: Examine the superdisintegrants market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the superdisintegrants market for a structured understanding.
•Key Players Overview: Analyze major players in the superdisintegrants market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the superdisintegrants market.
•Segment Contributions: Evaluate how different segments drive overall growth in the superdisintegrants market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the superdisintegrants market.
•Industry Challenges: Identify potential risks and obstacles affecting the superdisintegrants market.
•Competitive Landscape: Review strategic developments in the superdisintegrants market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Catalyst Driving Superdisintegrants Market Evolution in 2025: Rising Generic Drug Production Fuels The Market Growth Driver here
News-ID: 3934634 • Views: …
More Releases from The Business Research Company
Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025?
The market for subcutaneous immunoglobulin (SCIG) has seen a swift expansion in the recent past. The market size is projected to escalate from $12.72 billion in 2024 to $14.39 billion in 2025, reflecting a compound annual growth…
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Ranibizumab Market Size By 2025?
The market for ranibizumab has experienced steady expansion in the past few years, with projections stating it will increase from $2.66 billion in 2024 to $2.76 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.6%. The growth…
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peptide And Oligonucleotide CDMO Market Size Growth Forecast: What to Expect by 2025?
In recent years, the peptide and oligonucleotide cdmo market has witnessed a swift escalation in its size. From $2.16 billion in 2024, it is projected to surge up to $2.42 billion in 2025 with a compound…
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chroni …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Oral Solid Dosage Pharmaceutical Formulation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for oral solid dosage pharmaceutical formulations has seen robust growth in the last few years. Its size is expected to increase from $618.34 billion in 2024 to $653.26 billion in…
More Releases for Superdisintegrants
Simplified Superdisintegrants Market Analysis
Welcome to an extensive exploration into the realm of superdisintegrants, a crucial component of the pharmaceutical industry. As of 2023, the global superdisintegrants market boasts a valuation of USD 394.8 million, largely propelled by the surging demand for mouth-dissolving films, renowned for their remarkably reduced side effects. This market is poised for substantial expansion, with a projected Compound Annual Growth Rate (CAGR) of 7.3% expected to persist throughout the forecast…
Global Superdisintegrants Market Size - Forecasts to 2026
As per the research conducted by GME, the Global Superdisintegrants Market will grow with a CAGR value of 7.5 per cent. Expansion in the generic market, the emergence of new superdisintegrants for the pharmaceutical sector, rising geriatric population who have difficulty with swollen tablets or capsules, rising demands for superdisintegrants products, growing investment in R&D activities, and rising adoption rate of novel drug delivery systems are some of the factors…
Superdisintegrants Market outlook with industry review and forecasts
Superdisintegrants Market size is projected to experience significant growth from 2019 to 2025.
Pharmaceutical consumption continues to increase in order to meet the growing needs for patients suffering from various age-related and chronic diseases. According to the study conducted by the Organization for Economic Co-operation and Development (OECD), the pharmaceutical consumption is very high globally. Moreover, the solid dosage medicines still hold significant revenue in the overall pharmaceutical industry, thus increasing…
Global Superdisintegrants Market Research Report
This report studies the global Superdisintegrants market status and forecast, categorizes the global Superdisintegrants market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Ashland Global Holdings Inc. Roquette Frères S.A. FMC Corporation DFE Pharma Huber Corporation Nippon Soda Co., Ltd. The Dow…
Greater Research into Natural Superdisintegrants will Provide a Stimulus for the …
Global Superdisintegrants Market: Overview
Superdisintegrants are one among the different kinds of excipients used in the pharmaceutical industry for tablet-based drug delivery. Superdisintegrants are added to solid dosage forms such as pills or tablets to help them disintegrate when submerged in a liquid. The creation of a greater surface area of the tablet as it breaks into smaller fragments aids speedy drug substance release.
Browse to unlock the hidden opportunities in Superdisintegrants…
Superdisintegrants Market: Rise of a New Class of Natural Superdisintegrants wil …
Superdisintegrants are one among the different kinds of excipients used in the pharmaceutical industry for tablet-based drug delivery. Superdisintegrants are added to solid dosage forms such as pills or tablets to help them disintegrate when submerged in a liquid. The creation of a greater surface area of the tablet as it breaks into smaller fragments aids speedy drug substance release.
Despite the growing interest in different kinds of drug delivery mechanisms,…
